Authors: De Esch, IJP Mills, JEJ Perkins, TDJ Romeo, G Hoffmann, M Wieland, K Leurs, R Menge, WMPB Nederkoorn, PHJ Dean, PM Timmerman, H

Citation: Ijp. De Esch et al., Development of a pharmacophore model for histamine H-3 receptor antagonists, using the newly developed molecular modeling program SLATE, J MED CHEM, 44(11), 2001, pp. 1666-1674

Authors: De Esch, IJP Gaffar, A Menge, WMPB Timmerman, H

Citation: Ijp. De Esch et al., Synthesis and histamine H-3 receptor activity of 4-(n-alkyl)-1H-imidazolesand 4-(omega-phenylalkyl)-1H-imidazoles, BIO MED CH, 7(12), 1999, pp. 3003-3009

Authors: De Esch, IJP Vollinga, RC Goubitz, K Schenk, H Appelberg, U Hacksell, U Lemstra, S Zuiderveld, OP Hoffmann, M Leurs, R Menge, WMPB Timmerman, H

Citation: Ijp. De Esch et al., Characterization of the binding site of the histamine H-3 receptor. 1. Various approaches to the synthesis of 2-(1H-imidazol-4-yl)cyclopropylamine and histaminergic activity of (1R,2R)- and (1S,2S)-2-(1H-imidazol-4-yl)cyclopropylamine, J MED CHEM, 42(7), 1999, pp. 1115-1122

Authors: De Esch, IJP Nederkoorn, PHJ Timmerman, H

Citation: Ijp. De Esch et al., Molecular modelling studies of histamine H-3 receptor ligands, PHARMCHEM L, 30, 1998, pp. 223-241